Week 4 - Neoplasia Flashcards
Characteristics of benign neoplasm
Small, encapsulated, well differentiated, cells often retain normal function, no invasion, non lethal except if impinges on surrounding tissue and vessel, non metastasising, no pleomorphism
Characteristics of malignant neoplasm
Large, non encapsulated, show loss of differentiation, cells lose normal function, invasion of normal tissue, metastasise, potentially lethal, pleomorphic
Benign neoplasm nomenclature
-oma
Malignant neoplasm nomenclature
carcinoma, sarcoma
Carcinoma
Neoplasm arising from epithelial tissue
Sarcoma
Neoplasms arising in non-epithelial tissues
Screening methods used to assist in early diagnosis and treatment of breast cancer
Mammography and ultrasonography, fine needle aspiration cytology, core biopsy/vacuum assisted biopsy, self-palpitation/examination, clinical breast exam
Sessile
Absence of stalk
Pedunculated
Attached to the surface by a narrow elongated stalk
Importance of polyps recognition and treatment
Polyps = precursor to malignancy
Typical consequences of benign tumour in uterus
Abnormal uterine bleeding, urination frequency (increasing tumour puts pressure on urinary bladder), abdominal pain, pressure on colonic area
Tumour
Swelling
Neoplasm
Abnormal mass of tissue
Hyperplasia
Increased cell number
Hypertrophy
Increased cell size
Metaplasia
Change from normal cell type to another cell type in response to stimuli
Dysplasia
Disordered/abnormal cell growth
Carcinoma in-situ
Cancer that sits above the basement membrane, hasn’t invaded the tissue
Invasive carcinoma
Cells have invaded the basement membrane
Anaplastic
No differentiation
Pleomorphism
Variation in size and shape of cell or nucleus
Nuclear atypia in neoplastic cells
Hyperchromasia, Increased n:c ratio, mitotic activity, loss of polarity
Hyperchromasia
Dark nuclei due to increased amount of chromatin
Metastasis
Process by which primary malignant neoplasm gives rise to secondary tumours at other sites
Spread of malignant tumours
Direct invasion, lymphatic invasion, vascular invasion, transcoelomic spread
Vascular invasion
Invasion to other organs in the vascular pathway
Grade
Measure of how aggressively a tumour behaves (differentiation and mitotic activity)
Stage
How far the tumour has advanced at the time of diagnosis
Stage can be described through
Features of the tumour (size, extent of local invasion), nodal involvement, metastasis
Molecular techniques in clinical practice can be used for
Diagnosis, prognosis, therapeutics
FISH
Fluorescent In Situ Hybridization
Techniques used to differentiate lipoma vs liposarcoma
FISH for specific translocations, immunohistochemistry, cytogenetics
Techniques used to identify lymphoma
PCR, FISH
Mutations that cause lung adenocarcinomas
EGFR mutations
Mutations that cause melanomas
BRAF mutations
Breast carcinoma molecular techniques
Tissue microarray (gene chips), microarray technology
Carcinogenesis
Process that results in transformation of normal cells to neoplastic cells through permanent genetic alteration
Carcinogen
Cancer causing agent
Mechanism of carcinogenesis
Multistep process: Accumulation of permanent genetic alterations & tumour progression
Proto-oncogenes
Promoters of cell growth
Anti-oncogenes
Restrict cell growth
Identification of carcinogens
Epidemiological studies, carcinogenic effects in laboratory animals, transforming effects on cell cultures and mutagenicity testing in bacteria
Causes of cancer
Behavioural and occupational risks, chemicals, irradiation, hormones, physical agent (asbestos), diet, virus/bacterial preneoplastic dysplasia, autoimmune diseases
Metabolic pathways for conversion of chemical procarcinogens into active ultimate carcinogen
Polycyclic aromatic hydrocarbons, aromatic amines, nitrosamines from ingested nitrates and nitrites
Tumours caused by HPV
Common wart (squamous cell papilloma), cervical carcinoma
Tumours caused by Epstein-Barr virus
Burkitt’s lymphoma, nasopharyngeal cancer
Tumours caused by Hep B and C virus
Hepatocellular carcinoma
Tumours caused by human herpesvirus-8
Kaposi’s sarcoma, primary effusion lymphoma
Tumours caused by Human T-cell lymphotropic virus 1
Adult T-cell leukaemia/lymphoma
Host factors in carcinogenesis
Race, diet, constitutional factors, premalignant lesions and conditions, transplacental exposure, congenital
Cellular and molecular events in carcinogenesis
Multistep process, may require initiating and promoting agents, growth persists in the absence of the causative agents, genetic alterations of oncogenes and tumour suppressor genes
Initiation
Where carcinogen induces genetic alteration(s) that give(s) transformed cells its neoplastic potential
Promotion
Stimulation of clonal proliferation of the initiated transformed cell
Progression
Process culminating in malignant behaviour characterised by invasion and its consequences
How do abnormalities in genes regulating cell proliferation underpin neoplasia
Activation of oncogenes to stimulate growth, loss of genes controlling proliferation, loss of normal control mechanisms for eliminating genetically damaged cells, loss of gene products that repair damaged DNA => DNA instability and mutation in oncogenes and tumour suppressor genes
Proto-oncogene
Genes that code for proteins involved in control of cell growth = switches for cell proliferation
Viral oncogene
Genes within virus that code for a protein
Cellular oncogene
Genes that code for protein in development of neoplasia
Mechanisms of oncogene activation
Proto-oncogenes form oncogenes through point mutation, translocation or gene amplification
Point mutation
Caused by a single nucleotide change resulting in changed amino acid
Translocation
Moves a gene or part of a gene from one chromosome to another
Gene amplification
Leads to raised protein levels
Oncogene nomenclature
3 letter code of the cancer in which first found
RAS
Rat sarcoma
MYC
Myelocytomatosis retrovirus
Prefix c
Cellular
Prefix v
Viral homologue
Clinical applications of oncogenes
Predictive marker in some common cancers, production of drugs that target oncogene, production of drugs that target components of signalling pathways
Example of proto-oncogene activated by point mutation
ras
Example of proto-oncogene activated by chromosomal translocation
bcl-2, abl
BCR-ABL
Philadelphia gene - translocation (9:22) => CML
Example of proto-oncogene activated by gene amplification
erb-B2 neu or HER2/neu, erb-B1
HER2
Cell membrane surface bound receptor tyrosine kinase
Function of HER2
Involved in signal transduction pathways leading to cell growth and differentiation
Role of p53
Regulate cell proliferation and trigger apoptosis
Cell cycle
M -> G1 -> S -> G2